Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales
BHC's fourth-quarter adjusted earnings and revenues beat estimates driven by Xifaxan. The guidance for 2025 is positive.
Stock of the Day: Howard Hughes Holdings whipsaws as Bill Ackman revises his plan to create the next Berkshire Hathaway
Bill Ackman's Pershing Square proposed to acquire 10 million newly issued Howard Hughes shares at $90 a share — up from $85 a ...